drug · antibody

emactuzumab

Phase 3updated 3mo ago

by SynOx Therapeutics Ltd🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.

targets

Macrophage colony-stimulating factor 1 receptor

all catalysts(0)

nothing on the calendar yet

Trials studying emactuzumab

phase3A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Studyactive not recruitingn=1,000
phase3Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)active not recruitingn=128

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

emactuzumab

Phase 3updated 3mo ago

by SynOx Therapeutics Ltd🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.

targets

Macrophage colony-stimulating factor 1 receptor

all catalysts(0)

nothing on the calendar yet

Trials studying emactuzumab

phase3A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Studyactive not recruitingn=1,000
phase3Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)active not recruitingn=128

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

emactuzumab

targets

all catalysts(0)

Trials studying emactuzumab

News(0)

Report a data issue

comments(0)

emactuzumab

targets

all catalysts(0)

Trials studying emactuzumab

News(0)

Report a data issue

comments(0)